Lawyers for US cancer sufferers challenge Bayer’s $7.25bn Roundup settlement deal

Proposed settlement would pay users of glyphosate-based weedkiller who have non-Hodgkin lymphoma $10,000 to $165,000

A group of 14 law firms representing nearly 20,000 plaintiffs is seeking to intervene in Bayer's proposed class action settlement of Roundup litigation, citing concerns that the deal will not be fair to cancer sufferers.

The group filed both a motion to intervene and a motion for an extension of time for court preliminary approval of the deal in St Louis city circuit court in Missouri late on February 24.

This story is co-published with the New Lede, a journalism project of the Environmental Working Group